UC Davis Institute for Psychedelics and Neurotherapeutics

Dive into the fascinating world of #neuroplasticity and #psychedelics with our Associate Director John A. Gray, MD PhD on the Audible River Podcast! Explore how psychedelics are unlocking new potential in #neuroscience and #mentalhealth treatment. Listen here or wherever you get your podcasts:

The Biden administration has finalized new regulations to ensure that health insurers cover mental health care as comprehensively as physical health conditions. The rule aims to close loopholes and prevent insurers from using more restrictive processes for mental health. Everyone should have access to proper care. We should be treating mental health conditions as readily as we treat broken bones! #MentalHealthParity #HealthcareReform #MentalHealthAccess Read more:

Don't forget to register for Cure Addiction Now's free public forum and webinar! The virtual forum begins tomorrow, September 7th. Sign up now at the link below. #CAN #SUD #CureAddictionNow

Our paper on psychedelic-induced neuroplasticity has now been cited 1,000 times! This work set the stage for our institute's mission and?continues to shape the future of #psychedelic research and therapeutic #innovation.?Here's to many more breakthroughs and the continued impact of this pioneering work! Congratulations to coauthors David E. Olson, Megan Dennis, Kimberley McAllister, Kassandra Ori-McKenney, and John A. Gray, MD PhD. You can read the paper?that started it all at the link below. https://lnkd.in/dMEYr_e #ucdavis UC Davis College of Letters and Science University of California, Davis - School of Medicine UC Davis Center for Neuroscience

Register for Cure Addiction Now's free public forum and webinar! CAN is a nonprofit organization dedicated to finding treatments for addiction, and this forum is an excellent opportunity for the public to interact with the scientists working in this area. Register for the virtual forum happening on September 7th. #CAN #SUD #CureAddictionNow

Great opportunity at the IPN if you are interested in CNS drug discovery!

The initial review date for the open Director of Pharmacology position with the IPN is approaching! Please submit your applications before 8/31/24 for consideration in this first review period. If you have a PhD in pharmacology, neuroscience, physiology, or a related field, we'd love to see you apply. ?? Location: Davis, CA ?? Apply Here: https://lnkd.in/gAEeKPJN #professionalresearcher #jobopening #pharmacology

IPN postdoctoral scholar Dr. Cassandra Hatzipantelis has published a journal club in The Journal of Neuroscience, highlighting recent work by researchers from Yokohama City University. They identified a role for the orphan receptor, GPR143, in producing the major motor syndromes associated?with the antipsychotic drug haloperidol. This opens up exciting new avenues for drug discovery. Read more here:

Congratulations to our Associate Director, John A. Gray, MD PhD, for receiving UC Davis Graduate Studies' 2024 Graduate Program Advising and Mentoring Award. This recognition highlights his commitment to guiding and supporting the next generation of researchers! We're proud to have such a dedicated mentor on our team, fostering growth and innovation.

The UK's NHS deemed the new #Alzheimer's drug Lecanemab cost-prohibitive, making it only?available privately. For reference,?the drug costs ~$20K per year in the US. As we witness ongoing accessibility barriers to life-changing medications, it’s a reminder of the importance of advancing research in all therapeutic areas. A key aim of our research is to challenge the notion that only the wealthy can access quality care. We hope to make novel treatments as accessible as possible, breaking down the barriers that continue to put innovative therapies out of reach for so many. Read more about the Lecanemab decision here: https://lnkd.in/gDEEkRup #TreatmentForAll #EquitableAccess #PsychedelicResearch #MentalHealth?